Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 49

1.

Cost-effectiveness of inhaled corticosteroids in adults with mild-to-moderate asthma: results from the asthma policy model.

Paltiel AD, Fuhlbrigge AL, Kitch BT, Liljas B, Weiss ST, Neumann PJ, Kuntz KM.

J Allergy Clin Immunol. 2001 Jul;108(1):39-46.

PMID:
11447380
[PubMed - indexed for MEDLINE]
2.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
[PubMed - indexed for MEDLINE]
3.

A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.

Buxton M, Caine N, Chase D, Connelly D, Grace A, Jackson C, Parkes J, Sharples L.

Health Technol Assess. 2006 Aug;10(27):iii-iv, ix-xi, 1-164. Review.

PMID:
16904046
[PubMed - indexed for MEDLINE]
Free Article
4.

The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.

Garside R, Pitt M, Anderson R, Rogers G, Dyer M, Mealing S, Somerville M, Price A, Stein K.

Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. Review.

PMID:
17999840
[PubMed - indexed for MEDLINE]
Free Article
5.

A cost-effectiveness analysis of first-line controller therapies for persistent asthma.

Shih YC, Mauskopf J, Borker R.

Pharmacoeconomics. 2007;25(7):577-90. Review.

PMID:
17610338
[PubMed - indexed for MEDLINE]
6.

The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.

Fox M, Mealing S, Anderson R, Dean J, Stein K, Price A, Taylor RS.

Health Technol Assess. 2007 Nov;11(47):iii-iv, ix-248. Review.

PMID:
17999842
[PubMed - indexed for MEDLINE]
Free Article
7.

A systematic review and economic model of the clinical and cost-effectiveness of immunosuppressive therapy for renal transplantation in children.

Yao G, Albon E, Adi Y, Milford D, Bayliss S, Ready A, Raftery J, Taylor RS.

Health Technol Assess. 2006 Dec;10(49):iii-iv, ix-xi, 1-157. Review.

PMID:
17134597
[PubMed - indexed for MEDLINE]
Free Article
8.

The long-term cost effectiveness of treatments for benign prostatic hyperplasia.

DiSantostefano RL, Biddle AK, Lavelle JP.

Pharmacoeconomics. 2006;24(2):171-91. Review.

PMID:
16460137
[PubMed - indexed for MEDLINE]
9.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
[PubMed - indexed for MEDLINE]
10.

Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.

Brocklebank D, Ram F, Wright J, Barry P, Cates C, Davies L, Douglas G, Muers M, Smith D, White J.

Health Technol Assess. 2001;5(26):1-149. Review.

PMID:
11701099
[PubMed - indexed for MEDLINE]
Free Article
11.
12.

Clinical and cost-effectiveness of once-daily versus more frequent use of same potency topical corticosteroids for atopic eczema: a systematic review and economic evaluation.

Green C, Colquitt JL, Kirby J, Davidson P, Payne E.

Health Technol Assess. 2004 Nov;8(47):iii,iv, 1-120. Review.

PMID:
15527669
[PubMed - indexed for MEDLINE]
Free Article
13.

Hormonal therapies for early breast cancer: systematic review and economic evaluation.

Hind D, Ward S, De Nigris E, Simpson E, Carroll C, Wyld L.

Health Technol Assess. 2007 Jul;11(26):iii-iv, ix-xi, 1-134. Review.

PMID:
17610808
[PubMed - indexed for MEDLINE]
Free Article
14.

Initial corticosteroid therapy for asthma.

Gibson PG, Powell H.

Curr Opin Pulm Med. 2006 Jan;12(1):48-53. Review.

PMID:
16357579
[PubMed - indexed for MEDLINE]
15.

Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.

Griebsch I, Coast J, Brown J.

Pediatrics. 2005 May;115(5):e600-14. Review.

PMID:
15867026
[PubMed - indexed for MEDLINE]
16.

Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.

Woolacott N, Bravo Vergel Y, Hawkins N, Kainth A, Khadjesari Z, Misso K, Light K, Asseburg C, Palmer S, Claxton K, Bruce I, Sculpher M, Riemsma R.

Health Technol Assess. 2006 Sep;10(31):iii-iv, xiii-xvi, 1-239. Review.

PMID:
16948890
[PubMed - indexed for MEDLINE]
Free Article
17.

[Inhaled corticosteroids in asthma: a medico-economic analysis of clinical trials].

Vergnenègre A, Godard P, Atsou K, Chouaïd C.

Rev Mal Respir. 2008 Apr;25(4):375-89. Review. French.

PMID:
18536625
[PubMed - indexed for MEDLINE]
18.

Efficacy of inhaled corticosteroids in asthma.

Barnes PJ.

J Allergy Clin Immunol. 1998 Oct;102(4 Pt 1):531-8. Review.

PMID:
9802359
[PubMed - indexed for MEDLINE]
19.

The cost of asthma: can it be reduced?

Mellis CM, Peat JK, Woolcock AJ.

Pharmacoeconomics. 1993 Mar;3(3):205-19. Review.

PMID:
10146944
[PubMed - indexed for MEDLINE]
20.

Antiviral therapies for herpes zoster infections. Are they economically justifiable?

Smith KJ, Roberts MS.

Pharmacoeconomics. 2000 Aug;18(2):95-104. Review.

PMID:
11067653
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk